HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

SIMPLE SUMMARY: HER2 testing in endometrial cancer (EC) has gained renewed interest as a therapeutic target. However, HER2 status has not been investigated in the context of the molecular EC classification. Here, we aimed to determine the clinicopathological features and prognostic significance of t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Vermij, Lisa, Horeweg, Nanda, Leon-Castillo, Alicia, Rutten, Tessa A., Mileshkin, Linda R., Mackay, Helen J., Leary, Alexandra, Powell, Melanie E., Singh, Naveena, Crosbie, Emma J., Smit, Vincent T.H.B.M., Creutzberg, Carien L., Bosse, Tjalling
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7795222/
https://ncbi.nlm.nih.gov/pubmed/33375706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010044
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados